Inventor · disambiguated record
Philip Keegan
Also filed as: KEEGAN PHILIP · KEEGAN PHILIP MICHAEL
8 granted patents·4 pending applications·52 citations·filing 2017–2025
85Inventor score
Top patents by PatentIndex Score
12 records- 0196US9801784B2Anaerobic blood storage containersNEW HEALTH SCIENCES INC·Filed 2017·Granted Oct 31, 2017·30 cites·20 claims
- 0293US10058091B2Oxygen reduction disposable kits, devices and methods of use thereofNEW HEALTH SCIENCES INC·Filed 2017·Granted Aug 28, 2018·11 cites·20 claims
- 0392US11090331B2Methods and treatment for reducing the risk of an inflammatory responseHEMANEXT INC·Filed 2020·Granted Aug 17, 2021·3 cites·19 claims
- 0489US11638421B2Oxygen reduction disposable kits, devices and methods of use thereofHEMANEXT INC·Filed 2022·Granted May 2, 2023·1 cites·20 claims
- 0584US12201584B2Anaerobic blood storage containersHEMANEXT INC·Filed 2020·Granted Jan 21, 2025·1 cites·20 claims
- 0683US11350626B2Oxygen reduction disposable kits, devices and methods of use thereof (ORDKit)HEMANEXT INC·Filed 2018·Granted Jun 7, 2022·3 cites·19 claims
- 0782US2025268792A1Anaerobic Blood Storage ContainersHEMANEXT INC·Filed 2024·Application pending·0 cites
- 0879US10849824B2Anaerobic blood storage containersHEMANEXT INC·Filed 2017·Granted Dec 1, 2020·2 cites·20 claims
- 0976US11375709B2Oxygen reduction disposable kits, devices and methods of use thereofHEMANEXT INC·Filed 2019·Granted Jul 5, 2022·1 cites·18 claims
- 1074US2023047634A1Methods for Managing Adverse Events in Patient Populations Requiring TransfusionHEMANEXT INC·Filed 2022·Application pending·0 cites
- 1173US2025177440A1Methods for Managing Adverse Events in Patient Populations Requiring TransfusionHEMANEXT INC·Filed 2025·Application pending·0 cites
- 1256US2019388467A1Methods for managing adverse events in patient populations requiring transfusionNEW HEALTH SCIENCES INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philip Keegan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →